Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B B Rewari

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 15, 2014
Survival probability and predictors of mortality and retention in care among patients enrolled for first-line antiretroviral therapy, Andhra Pradesh, India, 2008-2011Ramesh Reddy Allam, Manoj V Murhekar, Tarun Bhatnagar, et al.
AIDS Care|December 18, 2014
Nevirapine-related adverse events among children switched from efavirenz to nevirapine as compared to children who were started on nevirapine-based antiretroviral therapy directlyG N Sanjeeva, V Sukanya, H B Pavithra, et al.
Cultural Diversity & Ethnic Minority Psychology|July 16, 2008
Correlates of relationship, psychological, and sexual behavioral factors for HIV risk among Indian womenR N Gupta, Gail E Wyatt, Soumya Swaminathan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 17, 2015
Implementation and Operational Research: High Loss to Follow-up Among Children on Pre-ART Care Under National AIDS Program in Madurai, South IndiaN Poorana Ganga Devi, Kumar M V Ajay, C Palanivel, et al.
Global Health Action|February 28, 2018
'M-TRACK' (mobile phone reminders and electronic tracking tool) cuts the risk of pre-treatment loss to follow-up by 80% among people living with HIV under programme settings: a mixed-methods study from Gujarat, IndiaKedar Mehta, Ajay M V Kumar, Sudhir Chawla, et al.
Public Health Action|December 5, 2017
Why are HIV-infected people not started on antiretroviral therapy? A mixed-methods study from Gujarat, IndiaS Chawla, K Shringarpure, B Modi, et al.
Journal of Epidemiology and Global Health|January 29, 2016
HIV-infected presumptive tuberculosis patients without tuberculosis: How many are eligible for antiretroviral therapy in Karnataka, India?Ajay M V Kumar, Anil Singarajipura, Balaji Naik, et al.
Plos One|June 23, 2009
Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in IndiaNeeraj Raizada, Lakbir Singh Chauhan, B Sai Babu, et al.
Plos One|June 12, 2020
HIV-1 pol gene diversity and molecular dating of subtype C from Sri LankaAjit Patil, Jayanthi P Elwitigala, Lilani Rajapaksa, et al.
BMC Infectious Diseases|July 10, 2020
Prevalence of HBV and HCV infections, Bhutan, 2017: Progress and next stepsN Tshering, G P Dhakal, U Wangchuk, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 15, 2014
Survival probability and predictors of mortality and retention in care among patients enrolled for first-line antiretroviral therapy, Andhra Pradesh, India, 2008-2011Ramesh Reddy Allam, Manoj V Murhekar, Tarun Bhatnagar, et al.
AIDS Care|December 18, 2014
Nevirapine-related adverse events among children switched from efavirenz to nevirapine as compared to children who were started on nevirapine-based antiretroviral therapy directlyG N Sanjeeva, V Sukanya, H B Pavithra, et al.
Cultural Diversity & Ethnic Minority Psychology|July 16, 2008
Correlates of relationship, psychological, and sexual behavioral factors for HIV risk among Indian womenR N Gupta, Gail E Wyatt, Soumya Swaminathan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 17, 2015
Implementation and Operational Research: High Loss to Follow-up Among Children on Pre-ART Care Under National AIDS Program in Madurai, South IndiaN Poorana Ganga Devi, Kumar M V Ajay, C Palanivel, et al.
Global Health Action|February 28, 2018
'M-TRACK' (mobile phone reminders and electronic tracking tool) cuts the risk of pre-treatment loss to follow-up by 80% among people living with HIV under programme settings: a mixed-methods study from Gujarat, IndiaKedar Mehta, Ajay M V Kumar, Sudhir Chawla, et al.
Public Health Action|December 5, 2017
Why are HIV-infected people not started on antiretroviral therapy? A mixed-methods study from Gujarat, IndiaS Chawla, K Shringarpure, B Modi, et al.
Journal of Epidemiology and Global Health|January 29, 2016
HIV-infected presumptive tuberculosis patients without tuberculosis: How many are eligible for antiretroviral therapy in Karnataka, India?Ajay M V Kumar, Anil Singarajipura, Balaji Naik, et al.
Plos One|June 23, 2009
Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in IndiaNeeraj Raizada, Lakbir Singh Chauhan, B Sai Babu, et al.
Plos One|June 12, 2020
HIV-1 pol gene diversity and molecular dating of subtype C from Sri LankaAjit Patil, Jayanthi P Elwitigala, Lilani Rajapaksa, et al.
BMC Infectious Diseases|July 10, 2020
Prevalence of HBV and HCV infections, Bhutan, 2017: Progress and next stepsN Tshering, G P Dhakal, U Wangchuk, et al.
Pageof 4